Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of cervical intrathecal baclofen in spinal cord injury
NL-OMON59449Phase 4Active, not recruiting
- Sponsor
- Roessingh
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baclofen in Muscle spasm, sponsored by Roessingh. Primary endpoints: Treatment safety based on carbon dioxide and sleep apnea thresholds, CPAP adjustment requirement and 1 more. Started Mar 2026; status: active, not recruiting.
02
Drugs
baclofen
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NL-OMON59449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59449.